Evidence map›Paper›PMID 40653822›Full record

ArticleFEBS open bio2025

Characterization of WAC interactions with R2TP and TTT chaperone complexes linking glucose and glutamine availability to mTORC1 activity.

Sofía Cabezudo, Natalia Cuervo, Carmen García-Martín, Andrés López-Perrote, Clara Reglero, Adrián Maqueda-Real, Ana González-Corpas, Marina Serna, Diego Megías, Alejo Efeyan and 2 more

Abstract read
In one paragraph

Article in FEBS open bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sofía CabezudoStructural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Natalia CuervoStructural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Carmen García-MartínStructural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Andrés López-PerroteStructural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Clara RegleroStructural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Adrián Maqueda-RealStructural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Ana González-CorpasStructural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Marina SernaStructural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Diego MegíasConfocal Microscopy Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Alejo EfeyanMolecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Solip ParkStructural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Oscar LlorcaStructural Biology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.ORCID https://orcid.org/0000-0001-5705-0699

Funding

Agencia Estatal de Investigación, Ministerio de Ciencia, Innovación y Universidades PID2020-114429RB-I00Agencia Estatal de Investigación, Ministerio de Ciencia, Innovación y Universidades PID2023-146110NB-I00Agencia Estatal de Investigación, Ministerio de Ciencia, Innovación y Universidades PRE2021-097532Autonomous Region of Madrid and co-funded by the European Social Fund and the European Regional Development Fund Y2018/BIO4747
6 · The paper itself

Abstract

TELO2-TTI1-TTI2 (TTT) and R2TP are multi-subunit chaperones that cooperate with HSP90 to assemble matured complexes of the PIKK family of kinases, including mTOR complex 1 (mTORC1). WAC, a protein previously implicated in transcription, H2B ubiquitination, and autophagy, was recently identified as a regulator of mTORC1 in response to glucose and glutamine availability, acting in concert with R2TP and TTT. However, the molecular basis of the interactions of WAC with R2TP and TTT and their role in mTORC1 regulation remains poorly defined. Here, we characterized the interactions of WAC with mTOR, R2TP, and TTT and how these are affected by nutrient conditions. Using purified proteins, we establish that WAC directly binds to mTOR-mLST8, R2TP, and TELO2, but not TTI1 and TTI2. In cells, WAC is part of complexes containing components of mTORC1, R2TP, and TTT, and these associations are modulated by nutrient availability. Notably, WAC and TELO2 strongly associate with mTOR under glucose and glutamine deprivation, and these interactions are weakened minutes after nutrient refeeding. These dynamics correlate with changes in mTORC1 activity. Transcriptomic and proteomic analysis shows that WAC, mTOR, R2TP, and TTT are co-expressed across several human cancers, supporting that WAC is part of a functional pathway with mTOR, R2TP, and TTT. Together, our findings reveal the formation and disassembly of a WAC complex with mTOR and TELO2 that contributes to regulate mTORC1 in response to glucose and glutamine availability.

Indexed as

GlucoseGlutamineMechanistic Target of Rapamycin Complex 1Molecular ChaperonesHEK293 CellsHumansTOR Serine-Threonine KinasesGlucoseGlutamineMechanistic Target of Rapamycin Complex 1Molecular ChaperonesTOR Serine-Threonine KinasesmTORC1R2TPRUVBL1‐RUVBL2TELO2WAC

Identifiers

PMID40653822
PMCPMC12582974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.